{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:07:50Z","timestamp":1792454870915,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1494-7","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T08:00:21Z","timestamp":1513843221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-8043","authenticated-orcid":false,"given":"Silje","family":"Reiseter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnar","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Corander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Haydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Brit","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond Mogens","family":"Aal\u00f8kken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Taraldsrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri Opsahl","family":"Hetlevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Molberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"1494_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaut.2014.01.008","volume":"48\u201349","author":"C Tani","year":"2014","unstructured":"Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, Bombardieri S. The diagnosis and classification of mixed connective tissue disease. J Autoimmun. 2014;48\u201349:46\u20139.","journal-title":"J Autoimmun"},{"key":"1494_CR2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease\u2013an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148\u201359.","journal-title":"Am J Med"},{"key":"1494_CR3","first-page":"S111","volume":"33","author":"OA Moore","year":"2015","unstructured":"Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O, Morrisroe K, Thakkar V, Sahhar J, Roddy J, et al. Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clin Exp Rheumatol. 2015;33:S111\u2013116.","journal-title":"Clin Exp Rheumatol"},{"issue":"72","key":"1494_CR4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"2013","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger Jr TA, Carreira PE, et al. Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013;2013(72):1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"1494_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/art.1780380216","volume":"38","author":"NS Gendi","year":"1995","unstructured":"Gendi NS, Welsh KI, Van Venrooij WJ, Vancheeswaran R, Gilroy J, Black CM. HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic follow up of 46 patients. Arthritis Rheum. 1995;38:259\u201366.","journal-title":"Arthritis Rheum"},{"key":"1494_CR6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.semarthrit.2011.07.010","volume":"41","author":"S Cappelli","year":"2012","unstructured":"Cappelli S, Bellando Randone S, Martinovic D, Tamas MM, Pasalic K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, et al. \u201cTo be or not to be\u201d, ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012;41:589\u201398.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"1494_CR7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/acr.22872","volume":"68","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Crowson CS, Chowdhary VR, Ernste FC, Moder KG, Matteson EL. Epidemiology of mixed connective tissue disease 1985-2014: a population based study. Arthritis Care Res (Hoboken). 2016;68(12):1843\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1494_CR8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF02229703","volume":"15","author":"PB Frandsen","year":"1996","unstructured":"Frandsen PB, Kriegbaum NJ, Ullman S, Hoier-Madsen M, Wiik A, Halberg P. Follow-up of 151 patients with high-titer U1RNP antibodies. Clin Rheumatol. 1996;15:254\u201360.","journal-title":"Clin Rheumatol"},{"key":"1494_CR9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/rheumatology\/33.12.1117","volume":"33","author":"FH Hoogen van den","year":"1994","unstructured":"van den Hoogen FH, Spronk PE, Boerbooms AM, Bootsma H, de Rooij DJ, Kallenberg CG, van de Putte LB. Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies. Br J Rheumatol. 1994;33:1117\u201320.","journal-title":"Br J Rheumatol"},{"key":"1494_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005792-198007000-00001","volume":"59","author":"SH Nimelstein","year":"1980","unstructured":"Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore). 1980;59:239\u201348.","journal-title":"Medicine (Baltimore)"},{"key":"1494_CR11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.rmed.2008.12.018","volume":"103","author":"MN Fagundes","year":"2009","unstructured":"Fagundes MN, Caleiro MT, Navarro-Rodriguez T, Baldi BG, Kavakama J, Salge JM, Kairalla R, Carvalho CR. Esophageal involvement and interstitial lung disease in mixed connective tissue disease. Respir Med. 2009;103:854\u201360.","journal-title":"Respir Med"},{"key":"1494_CR12","doi-asserted-by":"crossref","unstructured":"Hetlevik SO, Flato B, Rygg M, Nordal EB, Brunborg C, Hetland H, Lilleby V. Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis. 2016;76(1):159\u201365. http:\/\/ard.bmj.com\/content\/76\/1\/159.long .","DOI":"10.1136\/annrheumdis-2016-209522"},{"key":"1494_CR13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2013.12.079","volume":"171","author":"P Ungprasert","year":"2014","unstructured":"Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA. Cardiac involvement in mixed connective tissue disease: a systematic review. Int J Cardiol. 2014;171:326\u201330.","journal-title":"Int J Cardiol"},{"key":"1494_CR14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3899\/jrheum.121272","volume":"40","author":"A Hajas","year":"2013","unstructured":"Hajas A, Szodoray P, Nakken B, Gaal J, Zold E, Laczik R, Demeter N, Nagy G, Szekanecz Z, Zeher M, et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol. 2013;40:1134\u201342.","journal-title":"J Rheumatol"},{"key":"1494_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","volume":"55","author":"R Gunnarsson","year":"2016","unstructured":"Gunnarsson R, El-Hage F, Aalokken TM, Reiseter S, Lund MB, Garen T, Norwegian M, Molberg O. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease. Rheumatology (Oxford). 2016;55:103\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"1494_CR16","doi-asserted-by":"crossref","unstructured":"Reiseter S, Gunnarsson R, Mogens Aalokken T, Brit Lund M, Mynarek G, Corander J, Haydon J, Molberg O. Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study. Rheumatology (Oxford). 2017. https:\/\/doi.org\/10.1093\/rheumatology\/kex077 .","DOI":"10.1093\/rheumatology\/kex077"},{"key":"1494_CR17","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/kes430","volume":"52","author":"R Gunnarsson","year":"2013","unstructured":"Gunnarsson R, Andreassen AK, Molberg O, Lexberg AS, Time K, Dhainaut AS, Bertelsen LT, Palm O, Irgens K, Becker-Merok A, et al. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatology (Oxford). 2013;52:1208\u201313.","journal-title":"Rheumatology (Oxford)"},{"key":"1494_CR18","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/0961203312456751","volume":"21","author":"P Szodoray","year":"2012","unstructured":"Szodoray P, Hajas A, Kardos L, Dezso B, Soos G, Zold E, Vegh J, Csipo I, Nakken B, Zeher M, et al. Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus. 2012;21:1412\u201322.","journal-title":"Lupus"},{"key":"1494_CR19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.rdc.2005.04.005","volume":"31","author":"IE Lundberg","year":"2005","unstructured":"Lundberg IE. The prognosis of mixed connective tissue disease. Rheum Dis Clin North Am. 2005;31:535\u201347. vii-viii.","journal-title":"Rheum Dis Clin North Am"},{"key":"1494_CR20","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288\u201391.","journal-title":"J Rheumatol"},{"key":"1494_CR21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirjak L, Denton CP, Distler O, Hachulla E, et al. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis. 2017;76:270\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1494_CR22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.2010.143792","volume":"70","author":"R Gunnarsson","year":"2011","unstructured":"Gunnarsson R, Molberg O, Gilboe IM, Gran JT, Group PS. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011;70:1047\u201351.","journal-title":"Ann Rheum Dis"},{"key":"1494_CR23","first-page":"328","volume":"16","author":"D Alarcon-Segovia","year":"1989","unstructured":"Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol. 1989;16:328\u201334.","journal-title":"J Rheumatol"},{"key":"1494_CR24","unstructured":"Kasukawa RS, Gordon C. Mixed connective tissue disease and anti-nuclear antibodies: proceedings of the International Symposium on Mixed Connective Tissue Disease and Anti-nuclear Antibodies, Tokyo, 29-30 August 1986\/editors, Reiji Kasukawa, Gordon C. Sharp. In International Symposium on Mixed Connective Tissue Disease and Anti-nuclear Antibodies 1986: Tokyo, Japan: Amsterdam; New York: Excerpta Medica; New York, NY, USA: Elsevier Science Pub. Co.; 1987"},{"key":"1494_CR25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"1494_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","volume":"30","author":"R Gunnarsson","year":"2016","unstructured":"Gunnarsson R, Hetlevik SO, Lilleby V, Molberg O. Mixed connective tissue disease. Baillieres Best Pract Res Clin Rheumatol. 2016;30:95\u2013111.","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"1494_CR27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/rheumatology\/keu310","volume":"54","author":"ST Flam","year":"2015","unstructured":"Flam ST, Gunnarsson R, Garen T, Norwegian Mctd Study Group, Lie BA, Molberg O. The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases. Rheumatology (Oxford). 2015;54:528\u201335.","journal-title":"Rheumatology (Oxford)."},{"key":"1494_CR28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","volume":"76","author":"R Vollenhoven van","year":"2017","unstructured":"van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balazova P, Bonfa E, Bootsma H, et al. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Ann Rheum Dis. 2017;76:554\u201361.","journal-title":"Ann Rheum Dis"},{"key":"1494_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13317-014-0060-4","volume":"5","author":"A Ghirardello","year":"2014","unstructured":"Ghirardello A, Borella E, Beggio M, Franceschini F, Fredi M, Doria A. Myositis autoantibodies and clinical phenotypes. Auto Immun Highlights. 2014;5:69\u201375.","journal-title":"Auto Immun Highlights"},{"key":"1494_CR30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/BOR.0000000000000113","volume":"26","author":"RT Domsic","year":"2014","unstructured":"Domsic RT. Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement. Curr Opin Rheumatol. 2014;26:646\u201352.","journal-title":"Curr Opin Rheumatol"},{"key":"1494_CR31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/annrheumdis-2016-209489","volume":"76","author":"TR Wilhelm","year":"2017","unstructured":"Wilhelm TR, Magder LS, Petri M. Remission in systemic lupus erythematosus: durable remission is rare. Ann Rheum Dis. 2017;76:547\u201353.","journal-title":"Ann Rheum Dis"},{"key":"1494_CR32","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/0961203315575586","volume":"24","author":"MF Carpintero","year":"2015","unstructured":"Carpintero MF, Martinez L, Fernandez I, Romero AC, Mejia C, Zang YJ, Hoffman RW, Greidinger EL. Diagnosis and risk stratification in patients with anti-RNP autoimmunity. Lupus. 2015;24:1057\u201366.","journal-title":"Lupus"},{"key":"1494_CR33","first-page":"1934","volume":"31","author":"AG Uribe","year":"2004","unstructured":"Uribe AG, Vila LM, McGwin Jr G, Sanchez ML, Reveille JD, Alarcon GS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2\u00a0K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004;31:1934\u201340.","journal-title":"J Rheumatol"},{"key":"1494_CR34","doi-asserted-by":"crossref","unstructured":"Hoffmann-Vold AM, Aalokken TM, Lund MB, Garen T, Midtvedt O, Brunborg C, Gran JT, Molberg O. Predictive value of serial HRCT analyses and concurrent lung function tests in systemic sclerosis. Arthritis Rheumatol. 2015;67(8):2205\u201312.","DOI":"10.1002\/art.39166"},{"key":"1494_CR35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/acr.20648","volume":"64","author":"MB Urowitz","year":"2012","unstructured":"Urowitz MB, Gladman DD, Ibanez D, Fortin PR, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, et al. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken). 2012;64:132\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1494_CR36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L","volume":"42","author":"MA Burdt","year":"1999","unstructured":"Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899\u2013909.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1494-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T07:14:54Z","timestamp":1570518894000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1494-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1494-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"284"}}